Browse result page of THPdb

The total number entries retrieved from this search are 11

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1033	ThPPIDTh1006	NameBivalirudin	Peptide SequenceFPRPGGGGNGDFEEIPEEYL Full view	Length20	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandAngiox	CompanyThe Medicines Company UK Ltd	Physical AppearancePowder for concentrate for solution	Route of AdministartionInjection	CategoryAntithrombins	TargetProthrombin
ID1151	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandHelixate FS	CompanyN.A.	Physical AppearanceSterile, stable, purified, nonpyrogenic, dried concentrate	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1152	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandHemofil M	CompanyN.A.	Physical AppearanceDry concentrate	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1389	ThPPIDTh1062	NameRituximab	Peptide SequenceHeavy Chain: QVQLQQP Full view	Length664	Functional ClassificationIIa	DiseaseCancer/Immunological	BrandRituxan	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, clear, colorless, preservative-free liquid concentrate	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents, Immunologic Factors and Antirheumatic Agents	TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
ID1466	ThPPIDTh1090	NameDaclizumab	Peptide SequenceQVQLVQSGAEVKKPGSSVKV Full view	Length674	Functional ClassificationIIa	DiseaseImmunologicals	BrandZenapax	CompanyRoche	Physical AppearanceClear, sterile, colorless concentrate for further dilution and intravenous administration	Route of AdministartionIntravenous injection	CategoryImmunosuppressive Agents	TargetFusion glycoprotein F0,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1584	ThPPIDTh1125	NameGolimumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseImmunological	BrandSimponi Injection	CompanyN.A.	Physical AppearanceSterile concentrated solution of the golimumab antibody	Route of AdministartionIntravenous infusion	CategoryAntipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	TargetTumor necrosis factor
ID1636	ThPPIDTh1142	NameObinutuzumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseCancer	BrandGazyva	CompanyGenentech	Physical AppearanceSterile, clear, colorless to slightly brown, preservative free liquid concentrate	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents	TargetB-lymphocyte antigen CD20
ID1644	ThPPIDTh1147	NameNatalizumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Immunological	BrandTysabri	CompanyBiogen Idec Inc.	Physical AppearanceSterile, colorless, and clear to slightly opalescent concentrate	Route of AdministartionIntravenous infusion	CategoryImmunosuppressive agents	TargetN.A.
ID1724	ThPPIDTh1174	NameDaratumumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIc	DiseaseCancer	BrandDarzalex	CompanyJanssen Biotech, Inc.	Physical AppearanceSolution, concentrate	Route of AdministartionIntravenous	CategoryAntineoplastic Agents	TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
ID1808	ThPPIDTh1200	NameProthrombin complex concentrate	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseHematological Disorders	BrandKcentra	CompanyCsl Behring Ag	Physical AppearanceNanofiltered and Lyophilized non-activated four-factor Prothrombin Complex Concentrate	Route of AdministartionIntravenous	CategoryNA	TargetNA
ID1829	ThPPIDTh1219	NameAnti-thymocyte Globulin (Rabbit)	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandATG-Fresenius	CompanyGenzyme Inc.	Physical AppearanceConcentrate for solution for infusion.	Route of Administartion Intravenous	CategoryAntibody	TargetT-cell surface glycoprotein CD1a, Major histocompatibility complex class I-related gene protein, Integrin alpha-L, T-lymphocyte activation antigen CD86, Low affinity immunoglobulin gamma Fc region receptor II-b, T-cell surface glycoprotein CD4, Integrin beta-1, Integrin alpha-V, Integrin beta-3